Sumitomo Mitsui Trust Holdings, Inc. Amgen Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $168 Billion
- Q3 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,656,072 shares of AMGN stock, worth $566 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,656,072
Previous 1,702,010
2.7%
Holding current value
$566 Million
Previous $475 Million
1.66%
% of portfolio
0.28%
Previous 0.3%
Shares
34 transactions
Others Institutions Holding AMGN
# of Institutions
3,301Shares Held
428MCall Options Held
6.12MPut Options Held
5.85M-
Vanguard Group Inc Valley Forge, PA53.9MShares$18.4 Billion0.24% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$10 Billion0.3% of portfolio
-
Capital International Investors Los Angeles, CA19.2MShares$6.56 Billion0.92% of portfolio
-
Capital World Investors Los Angeles, CA18.8MShares$6.42 Billion0.76% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $183B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...